Fantini J - Search Results

1

Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry.

Garg H, Francella N, Tony KA, Augustine LA, Barchi JJ Jr, Fantini J, Puri A, Mootoo DR, Blumenthal R. Garg H, et al. Among authors: fantini j. Antiviral Res. 2008 Oct;80(1):54-61. doi: 10.1016/j.antiviral.2008.04.004. Epub 2008 May 19. Antiviral Res. 2008. PMID: 18538869 Free PMC article.

2

C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.

Augustin LA, Fantini J, Mootoo DR. Augustin LA, et al. Among authors: fantini j. Bioorg Med Chem. 2006 Feb 15;14(4):1182-8. doi: 10.1016/j.bmc.2005.09.044. Epub 2005 Oct 10. Bioorg Med Chem. 2006. PMID: 16216516

3

Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.

Bachan S, Fantini J, Joshi A, Garg H, Mootoo DR. Bachan S, et al. Among authors: fantini j. Bioorg Med Chem. 2011 Aug 15;19(16):4803-11. doi: 10.1016/j.bmc.2011.06.078. Epub 2011 Jul 1. Bioorg Med Chem. 2011. PMID: 21783371 Free PMC article.

4

A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection.

Lund N, Branch DR, Mylvaganam M, Chark D, Ma XZ, Sakac D, Binnington B, Fantini J, Puri A, Blumenthal R, Lingwood CA. Lund N, et al. Among authors: fantini j. AIDS. 2006 Feb 14;20(3):333-43. doi: 10.1097/01.aids.0000206499.78664.58. AIDS. 2006. PMID: 16439866

5

A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.

Nehete PN, Vela EM, Hossain MM, Sarkar AK, Yahi N, Fantini J, Sastry KJ. Nehete PN, et al. Among authors: fantini j. Antiviral Res. 2002 Dec;56(3):233-51. doi: 10.1016/s0166-3542(02)00130-4. Antiviral Res. 2002. PMID: 12406507

6

Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry.

Fantini J, Hammache D, Delézay O, Yahi N, André-Barrès C, Rico-Lattes I, Lattes A. Fantini J, et al. J Biol Chem. 1997 Mar 14;272(11):7245-52. doi: 10.1074/jbc.272.11.7245. J Biol Chem. 1997. PMID: 9054420 Free article.

7

Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 binding.

Faroux-Corlay B, Greiner J, Terreux R, Cabrol-Bass D, Aubertin AM, Vierling P, Fantini J. Faroux-Corlay B, et al. Among authors: fantini j. J Med Chem. 2001 Jun 21;44(13):2188-203. doi: 10.1021/jm0011124. J Med Chem. 2001. PMID: 11405656

8

Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 receptor: new tools to study virus-glycolipid interactions.

Villard R, Hammache D, Delapierre G, Fotiadu F, Buono G, Fantini J. Villard R, et al. Among authors: fantini j. Chembiochem. 2002 Jun 3;3(6):517-25. doi: 10.1002/1439-7633(20020603)3:6<517::AID-CBIC517>3.0.CO;2-N. Chembiochem. 2002. PMID: 12325007

9

Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.

Weber KT, Hammache D, Fantini J, Ganem B. Weber KT, et al. Among authors: fantini j. Bioorg Med Chem Lett. 2000 May 15;10(10):1011-4. doi: 10.1016/s0960-894x(00)00153-0. Bioorg Med Chem Lett. 2000. PMID: 10843204 Free article.

10

Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.

Fantini J, Hammache D, Delézay O, Piéroni G, Tamalet C, Yahi N. Fantini J, et al. Virology. 1998 Jul 5;246(2):211-20. doi: 10.1006/viro.1998.9216. Virology. 1998. PMID: 9657940 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters